NeuroSense Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.About NRSN
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS).
CEOAlon Ben-Noon
CEOAlon Ben-Noon
Employees15
Employees15
HeadquartersHerzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded2017
Founded2017
Employees15
Employees15
NRSN Key Statistics
Market cap27.78M
Market cap27.78M
Price-Earnings ratio-1.85
Price-Earnings ratio-1.85
Dividend yield—
Dividend yield—
Average volume439.54K
Average volume439.54K
High today$1.79
High today$1.79
Low today$1.00
Low today$1.00
Open price$1.77
Open price$1.77
Volume1.59M
Volume1.59M
52 Week high$2.60
52 Week high$2.60
52 Week low$0.5985
52 Week low$0.5985
People also own
Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.